EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CWH43 Suppresses Ferroptosis-Associated Vulnerability Through Redox Adaptation in Colorectal Cancer

Kuei-Yen Tsai iD, Po-Li Wei iD, Cheng-Chin Lee, Uyanga Batzorig iD, Chien-Yu Huang, Yu-Jia Chang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kuei-Yen Tsai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei medical university-Taipei medical university hospital, National Science and Technology Council, Taipei Medical University—Taipei Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is an iron-dependent form of regulated cell death that has emerged as a potential vulnerability in cancer cells under therapeutic stress. However, the mechanisms by which colorectal cancer cells modulate ferroptosis susceptibility remain incompletely understood. In this study, we investigated the role of CWH43, a glycosylphosphatidylinositol-anchor biogenesis-related protein whose role in chemotherapy response has been unclear, in regulating redox balance and ferroptosis-associated vulnerability in colorectal cancer. Integrative analyses of clinical datasets, transcriptomic profiling, and functional experiments were performed using gain- and loss-of-function approaches in CRC cell models. We found that elevated CWH43 expression was associated with adverse clinical outcomes and reduced responsiveness to chemotherapy. Functionally, CWH43 attenuated ferroptosis-associated vulnerability by reducing intracellular reactive oxygen species and lipid peroxidation. Mechanistically, CWH43 promoted redox-adaptive programs involving activation of NRF2-dependent antioxidant signaling, upregulation of the cystine transporter SLC7A11, increased intracellular glutathione availability, and suppression of lipid peroxidation. Genetic or pharmacological disruption of SLC7A11 restored ferroptosis susceptibility and sensitized CWH43-overexpressing colorectal cancer cells to therapeutic stress, whereas ferrostatin-1 partially restored cell viability following erastin-containing treatments. Collectively, these findings identify CWH43 as a regulator of redox adaptation that modulates ferroptosis-associated vulnerability in colorectal cancer, providing insights into stress-adaptive survival mechanisms and chemotherapy resistance in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsHumansOxidation-ReductionAmino Acid Transport System y+Lipid PeroxidationReactive Oxygen SpeciesNF-E2-Related Factor 2Cell Line, TumorGene Expression Regulation, NeoplasticGlutathioneDrug Resistance, NeoplasmAnimalsPiperazines

Stichwörter der Autor:innen

NRF2SLC7A11biomarkerchemotherapycolorectal cancerferroptosisresistance

Substanzen

SLC7A11 protein, humanAmino Acid Transport System y+Reactive Oxygen SpeciesNF-E2-Related Factor 2NFE2L2 protein, humanGlutathioneerastinPiperazines

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235041, Taiwan.
  • Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Center for Precision Medicine and Translational Cancer Research, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei 11031, Taiwan.

ORCID-Profile: Kuei-Yen Tsai, Po-Li Wei, Uyanga Batzorig, Yu-Jia Chang

Förderung

  • Taipei medical university-Taipei medical university hospital
  • National Science and Technology Council
  • Taipei Medical University—Taipei Medical University Hospital
  • National Science and Technology Council, Taiwan

Zitieren

APA

Tsai, K. Y., Wei, P. L., Lee, C. C., Batzorig, U., Huang, C. Y., & Chang, Y. J. (2026). CWH43 Suppresses Ferroptosis-Associated Vulnerability Through Redox Adaptation in Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198830

Vancouver

Tsai KY, Wei PL, Lee CC, Batzorig U, Huang CY, Chang YJ. CWH43 Suppresses Ferroptosis-Associated Vulnerability Through Redox Adaptation in Colorectal Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198830

BibTeX
@article{Tsai2026,
  author = {Tsai, Kuei-Yen and Wei, Po-Li and Lee, Cheng-Chin and Batzorig, Uyanga and Huang, Chien-Yu and Chang, Yu-Jia},
  title = {CWH43 Suppresses Ferroptosis-Associated Vulnerability Through Redox Adaptation in Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198830}
}
Kostenlos starten →